+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Tumor associated endometrial papillary syncytial change An epithelial alteration frequently accompanying endometrial adenocarcinoma



Tumor associated endometrial papillary syncytial change An epithelial alteration frequently accompanying endometrial adenocarcinoma



Modern Pathology 7(1): 92A




(PDF emailed within 1 workday: $29.90)

Accession: 034088573

Download citation: RISBibTeXText


Related references

Endometrial papillary syncytial change. A nonspecific alteration associated with active breakdown. American Journal of Clinical Pathology 99(6): 741-745, 1993

Wilms' tumor 1 protein expression in endometrial adenocarcinoma and endometrial intra-epithelial neoplasia. Journal of Obstetrics and Gynaecology Research 42(7): 870-875, 2017

Endometrial papillary syncytial change. Another perspective. American Journal of Clinical Pathology 99(6): 656-657, 1993

Endometrial epithelial metaplasias: proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. American Journal of Surgical Pathology 4(6): 525-542, 1980

Comparison of continuous human cell culture lines derived from serous papillary endometrial carcinoma and typical endometrial adenocarcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 28: 29, 1987

Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications. Gynecologic Oncology 71(1): 83-86, 1998

The clinical significance of K-ras mutation in endometrial "surface epithelial changes" and their associated endometrial adenocarcinoma. Gynecologic Oncology 142(1): 163-168, 2017

Alteration of the p53 Tumor Suppressor Gene and Activation of c-K- ras -2 Protooncogene in Endometrial Adenocarcinoma From Colorado. American Journal of Clinical Pathology 103(2): 224-230, 1995

Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado. American Journal of Clinical Pathology 103(2): 224-230, 1995

Atypical glandular cells of undetermined significance favor endometrial origin. Criteria for separating low grade endometrial adenocarcinoma from benign endometrial lesions. Acta Cytologica 46(3): 458-464, 2002

Normal endometrial stromal cells regulate 17β-estradiol-induced epithelial-mesenchymal transition via slug and E-cadherin in endometrial adenocarcinoma cells in vitro. Gynecological Endocrinology 33(1): 82-86, 2016

GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma. Turk Patoloji Dergisi 32(3): 141-147, 2017

G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines. Steroids 78(11): 1087-1091, 2014

Morphometric analysis of endometrial adenocarcinoma: 1. Does architectural dedifferentiation accompany deep invasion by endometrial adenocarcinoma?. International Journal of Gynecological Pathology 6(1): 12-19, 1987

Serious papillary endometrial adenocarcinoma. Zhonghua Fu Chan Ke Za Zhi 31(1): 48-51, 1996